Hovione Passes FDA Inspection
Hovione's plant in Portugal has successfully passed its twelfth FDA inspection in 18 months.
Hovione's plant in Loures, Portugal has passed a GMP and postmarket approval inspection by FDA. The inspection lasted five days as initially planned, and began on Sept. 23, 2013 was concluded on Sept. 27, 2013. At the closing meeting, the inspector was satisfied the company's GMP system, and the inspection was sucessful.
Hovione’s five plants were the object of 12 inspections in the last 18 months. These inspections were performed by health authorities, including five by FDA, three by the Portuguese Health Authority, one by the Irish Medicines Board, one by Korean health authorities, and two by China’s health authority.
Source: Hovione
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
